Research output per year
Research output per year
Personal profile
Education
- 2002-2010 Ph.D., Graduate Institute of Clinical Medicine, School of Medicine, Taipei Medical University
- 1990-1992 M.S., Graduate Institute of Pathology, College of Medicine, National Taiwan University
- 1983-1990 M.D., School of Medicine, Taipei Medical College
Experience
- 2009.02- Associate Professor, Department of Pathology, Taipei Medical University
- 1998.08-2009.01 Instructor, Department of Pathology, Taipei Medical University
- 1997.08-1998.07 Instructor, Tzu Chi Hospital
- 1996.08-1998.06 Attending Physician, Tzu Chi Hospital
- 1994.08-1996.07 Resident Physician, National Taiwan University Hospital
Research Interests
- Pathology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Chien-Jui Cheng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Simvastatin enhances the antitumor activity of temsirolimus through AMPK-associated metabolic modulation in clear-cell renal cell carcinoma
Chen, H. Y., Cheng, C. J., Hsu, T. H., Tung, S. Y., Chou, F. N., Satapathy, M. K. & Juan, S. H., 2026, (Accepted/In press) In: Naunyn-Schmiedeberg's Archives of Pharmacology.Research output: Contribution to journal › Article › peer-review
-
An unusual yet treatable cause of recurrent abdominal pain
Lu, C. H., Tsai, C. C., Cheng, C. J. & Tiong, C., Jun 2024, In: Clinics and Research in Hepatology and Gastroenterology. 48, 6, 102360.Research output: Contribution to journal › Comment/debate › peer-review
-
Dacomitinib-induced purpuric drug eruptions associated with IQGAP1 upregulation in a patient with lung adenocarcinoma
Chang, H.-C., Sheen, Y.-S., Ko, P.-H., Cheng, C.-J., Chu, C. Y., Hsiao, S.-H. & Lee, T.-H., Jul 2023, In: JDDG - Journal of the German Society of Dermatology. 21, 7, p. 795-797 3 p.Research output: Contribution to journal › Letter › peer-review
-
Dacomitinib-induzierte purpuriforme Arzneimittelreaktion mit IQGAP1-Hochregulierung bei einer Patientin mit Adenokarzinom der Lunge
Chang, H. C., Sheen, Y. S., Ko, P. H., Cheng, C. J., Chu, C. Y., Hsiao, S. H. & Lee, T. H., Jul 2023, In: JDDG - Journal of the German Society of Dermatology. 21, 7, p. 795-797 3 p.Research output: Contribution to journal › Letter › peer-review
-
The therapeutic effect of tanshinone IIA in mouse astrocytes after treatment with Angiostrongylus cantonensis fifth-stage larval excretory-secretory products
Chen, K. Y., Chen, Y. J., Cheng, C. J., Jhan, K. Y., Chiu, C. H. & Wang, L. C., Aug 2023, In: Journal of Microbiology, Immunology and Infection. 56, 4, p. 853-862 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus)